Save time and get answers to complex questions with AI chat
Atorvastatin side effects heart palpitations?Pramlintide fda approval date?Patent tenofovir alafenamide gilead?Tracleer online pharmacy?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for cosentyx
Short answer: No. There are no dose adjustments for Cosentyx (secukinumab) based solely on age in the labeling. What drives the dose instead: - The indication (e.g., plaque psoriasis, psoriatic arthritis, axial spondyloarthritis). - In many cases, dosing is also related to body weight, especially in adults. Notes by group: - Adults: Dosing is set by indication and sometimes weight; there isn’t a separate “older vs younger adult” adjustment. - Elderly: No age-based adjustment is specifically recommended, but as with all immunomodulators, monitor for infections and other safety concerns. - Pediatric use: There are pediatric dosing tables that are weight-based for certain approved indications (e.g., plaque psoriasis in children 6 years and older). The dosing for children is not the same as adults and is not solely age-based but weight-based and indication-specific. If you’d like, tell me the exact Cosentyx indication and the patient’s age and weight, and I’ll summarize the approved dosing for that scenario. Alternatively, I can point you to the specific dosing table in the prescribing information.
Other Questions About Cosentyx :